Tesamorelin
Tesamorelin, a GHRP, binds ghrelin receptors to stimulate growth hormone release, targeting visceral fat reduction through enhanced lipolysis and IGF-1 production. It activates GHSR-mediated pathways, improving lipid profiles and metabolic health, particularly in HIV-associated lipodystrophy, for which it is FDA-approved. Tesamorelin also supports muscle recovery and anti-aging effects